Brief: Ikena Oncology Reports Third Quarter Results

ImageneBio

07/11/2022 14:29

Nov 7 (Reuters) - Ikena Oncology Inc  IKNA.O :
    * IKENA ONCOLOGY REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND
PROVIDES A CORPORATE UPDATE
    * NEXT DEVELOPMENT CANDIDATE IN RAS PATHWAY TO BE ANNOUNCED
BY
YEAR END 2022
    * QTRLY LOSS PER SHARE $0.48
    * Q3 EARNINGS PER SHARE VIEW $-0.50 -- REFINITIV IBES DATA
    * AS OF SEPTEMBER 30, 2022, IKENA HAD $174.4 MILLION IN
CASH, CASH
EQUIVALENTS, AND MARKETABLE SECURITIES
    * BELIEVES CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES
TO BE
SUFFICIENT TO MEET ITS OPERATING REQUIREMENTS THROUGH MID-2024

Source text for Eikon:  ID:nGNX2Y28zl 
Further company coverage:  IKNA.O 
 ((reuters.briefs@thomsonreuters.com;))